• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Acamprosate found an effective and tolerable interventions for alcohol dependence

byConstance Wu
December 10, 2020
in StudyGraphics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Out of 43 interventions, acamprosate was the only intervention associated with greater likelihood of alcohol abstinence compared to placebo.

2. Acomprosate, naltrexone, and acomprosate-naltrexone were associated with lower dropout rates compared to placebo.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Excessive alcohol consumption has long been associated with a number of medical conditions, in particular liver disease. However, support and treatment for individuals with alcohol dependence are not always accessible: In the United Kingdom for example, only 1 in 4 with alcohol dependence seek treatment, and 82% of those don’t receive the specialist treatment they need. Therefore, supporting and treating alcohol dependence in a primary care setting is a potential consideration. The current study is a systematic review and meta-analysis, aiming to determine which interventions suitable for a primary care setting are most effective for alcohol abstinence. The findings showed that out of 43 pharmacological, psychosocial, and combined interventions, acamprosate was the sole intervention with sufficient evidence correlating it to a greater likelihood of alcohol abstinence for up to 12 months. As well, the only interventions with lower dropout rates were acamprosate, naltrexone, and acamprosate-naltrexone. The central strength of this study was the analysis of randomized controlled trials only, which compared interventions to a placebo or other control. The main weaknesses of this study were that most of the trials were small, single trials, with little high-quality data supporting interventions that would be suitable for primary care. Furthermore, few studies were conducted on combined pharmacological and/or psychosocial interventions.

Click here to read the study in BMJ

Relevant Reading: Therapeutic interventions for alcohol dependence in non-inpatient settings: a systematic review and network meta-analysis (protocol)

In-Depth [systematic review and meta-analysis]: This study analyzed 64 randomized controlled trials on interventions for adults with alcohol dependency who had undergone detoxification during the study or within 4 weeks prior. Outcomes measured include continuation of abstinence over the study period, to assess the intervention’s effectiveness, and the drop-out rate, to gauge the tolerability of the intervention. The results showed with moderate confidence that acamprosate was associated with increased odds of abstinence for up to 12 months, compared to placebo (odds ratio 1.86, 95% CI 1.49-2.33). A few interventions were also associated with increased odds, but with weak confidence, such as topiramate, sodium oxybate, and quietapine. No psychosocial interventions correlated to greater abstinence. In terms of drop-out rates, the interventions with reduced dropout rates compared to placebo (with moderate confidence) were acamprosate (OR 0.73, 95% CI 0.62-0.86), naltrexone (OR 0.70, 95% CI 0.50-0.98), and acamprosate-naltrexone combined (OR 0.30, 95% CI 0.13-0.67). Therefore, acamprosate was the only intervention in this systematic review and meta-analysis found to be effective and tolerable for abstinence in adult alcohol-dependence patients, with the potential for usage in primary care settings.

RELATED REPORTS

Methamphetamine use associated with cardiovascular disease in hospitalized patients

Alcohol recovery narratives are dynamic and may be composed of multiple dimensions

Primary care physicians underuse Medicare prevention and coordination codes

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: AcamprosateAlcoholAlcohol Dependencealcohol use disorderNaltrexoneprimary caresubstance use disorder
Previous Post

#VisualAbstract: Addition of indoximod to taxane chemotherapy does not improve survival in patients with metastatic breast cancer

Next Post

Major birth defects and chromosomal abnormalities significantly associated with increased cancer risk

RelatedReports

Carbon nanotubes ameliorate methamphetamine addiction in mice [PreClinical]
Cardiology

Methamphetamine use associated with cardiovascular disease in hospitalized patients

August 8, 2022
Greater prenatal alcohol exposure trajectories linked to impaired growth and neurodevelopment
Chronic Disease

Alcohol recovery narratives are dynamic and may be composed of multiple dimensions

July 25, 2022
Parental debt influences child socioemotional well-being
Chronic Disease

Primary care physicians underuse Medicare prevention and coordination codes

July 11, 2022
Large spike in drug use-associated infective endocarditis linked with opioid epidemic
Chronic Disease

Obsessive-compulsive disorder and obsessive-compulsive symptoms associated with an elevated risk of substance misuse

June 14, 2022
Next Post
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial

Major birth defects and chromosomal abnormalities significantly associated with increased cancer risk

The STORM trial: treatment refractory multiple myeloma patients experience response with selinexor

Weekly selinexor, bortezomib, and dexamethasone demonstrates improved survival in treatment-refractory multiple myeloma

#VisualAbstract: Increased incidence of sebaceous carcinomas among solid organ transplant recipients

#VisualAbstract: Increased incidence of sebaceous carcinomas among solid organ transplant recipients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Provision of 1-year mortality data for patients hospitalized with heart failure does not influence clinical decision-making – The REVEAL-HF trial
  • Genetic risk for hemochromatosis associated with abnormal iron deposition localized to motor circuits of the brain
  • Graded sensorimotor retraining may improve chronic lower back pain compared to sham procedure: The RESOLVE randomized clinical trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.